Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 262

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 262
---
, for the year ended December 31, 2022. For the year ended December
31, 2024, there were no charges related to share-based compensation.

18. NON-CONTROLLING INTEREST

On February 25, 2022, Aptorum Medical Limited
issued119shares to Clark Cheng in according to the appointment agreement, decreasing the equity interest of the Company from92% to91%. On February 1, 2023, Aptorum Medical Limited further issued122shares to Clark Cheng in according to the appointment agreement,
decreasing the equity interest of the Company from91% to90%. As a result, a total deficit of $67,766and $52,024, were reclassified
from additional paid-in capital to non-controlling interests within the Group’s consolidated financial statements for the years
ended December 31, 2023 and 2022, respectively.

In November 2024, the Group acquired10,000Class A Ordinary Shares
and5,850,000Class B Ordinary Shares of Scipio, achieving control over the entity. As a result of this acquisition, Scipio is no longer
classified as a VIE under the Group and it became a subsidiary under the Group.

19. NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted
loss per share:

                                                                    Year ended                         Year ended                         Year ended                     
                                                                    December 31,                       December 31,                       December 31,                   
                                                                    2024                               2023                               2022                           
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Numerator:                                                                                                                                                             
  Net loss attributable to Aptorum Group Limited                    $                 ( 4,267,806      $                 ( 2,824,647      $                 ( 9,799,560  
  Denominator:                                                                                                                                                           
  Weighted average shares outstanding (1)                                                                                                                                
  – Basic (1)                                                                           5,453,103                          4,521,133                          3,569,484  
  – Diluted (1)                                                                         5,453,103                          4,521,133                          3,569,484  
  Net loss per share attributable to Aptorum Group Limited (1)                                                                                                           
  – Basic (1)                                                       $                      ( 0.78      $                      ( 0.62      $                      ( 2.75  
  – Diluted (